Table 1 Clinical characteristics of Stenotrophomonas maltophilia bacteraemia Tawam Hospital 2000–2004

Age

   Adult

18

(72.0)

   Child

7

(28.0)

Hospital Acquired

25

(100)

Clinical Unit

   Adult Oncology

11

(44.0)

   Paediatric Oncology

5

(20.0)

   Intensive Care Unit⁺

3

(12.0)

   Renal Dialysis Unit

4

(16.0)

   Neonatal Intensive Care

1

(4.0)

   Paediatric Medical

1

(4.0)

Underlying Disease

   Malignancy

19

(76.0)

   End stage renal failure

4

(16.0)

   Prematurity

1

(4.0)

   End stage respiratory failure

1

(4.0)

   Immunocompromised

25

(100)

Source

   Line-associated

22

(88.0)

   Febrile neutropenia

1

(4.0)

   Pneumonia

1

(4.0)

   Skin soft tissue infection

1

(4.0)

Polymicrobial

9**

(36.0)

Treatment of line infection

   Line removal

11/12*

(91.7)

Antimicrobial therapy

   Cotrimoxazole

14/16*

(87.5)

Outcome

   Death

2

   Death attributed to S. maltophilia

0